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Cyclic GMP-AMP synthase (cGAS) is best known as an innate immune 
receptor that detects pathogen DNA in the cytosol. In this issue of 
EMBO Reports, Kaufmann and colleagues [1] report that cGAS has an 
additional role in innate immunity: It can also bind cyclic di-nucleotides 
(CDNs), signalling molecules produced by bacteria. The authors show 
that when extracellular CDNs are taken up by endocytosis, they bind to 
cGAS, causing it to form a complex with the CDN receptor STING 
(STimulator of INterferon Genes), thereby enhancing its activation. As 
cGAS is dispensable for the detection of intracellular CDNs, this work 
exemplifies how the localisation of pathogen-associated molecular 




Many bacteria produce CDNs, such as cyclic di-AMP or cyclic di-GMP, as 
signalling molecules. These bacterial messengers can also be detected by the 
innate immune system, and thus act as PAMPs during infection. When CDNs 
gain access to the cytosol of human or mouse cells, e.g. during infection with 
intracellular bacteria, they are detected by STimulator of INterferon Genes 
(STING) which triggers the expression of type I interferons. CDN binding to 
STING promotes its translocation from the endoplasmic reticulum (ER) to ER-
Golgi intermediate compartments (ERGICs) where STING activates the TANK 
binding kinase 1 (TBK1) and interferon regulatory factor 3 (IRF3) [2], which 
finally results in the transcription of interferon-β and other cytokines and 
chemokines (Fig. 1). STING is not only a receptor for CDNs, but also an 
adaptor in the signalling pathway following the detection of cytosolic DNA, as 
the cytosolic DNA receptor cyclic GMP-AMP synthase (cGAS) produces a 
mammalian cyclic di-nucleotide, cyclic GMP-AMP (cGAMP), that also 
activates STING [2]. 
 In this issue of EMBO Reports, Kaufmann and colleagues report that 
cGAS has an additional function in innate immunity, in that it can promote the 
activation of STING by extracellular bacterial CDNs [1]. The authors show that 
human and murine macrophages can take up CDNs by clathrin-dependent 
endocytosis, and respond to these PAMPs by producing interferon-β. The 
response to extracellular CDNs required 10- to 100-fold higher CDN 
concentrations than those used for direct delivery into the cytosol by digitonin-
mediated membrane permeabilisation, which may explain why a response to 
extracellular CDNs has not been observed previously. Using mouse bone 
marrow-derived macrophages (mBMDMs) or human THP-1 monocytes 
lacking cGAS, the authors demonstrate that cGAS specifically enhances the 
response to extracellular CDNs, but is dispensable for the detection of 
intracellular CDNs delivered by membrane permeabilisation. STING, on the 
other hand, is essential for the recognition of CDNs in both scenarios. The 
authors confirm that the role of cGAS in enhancing the interferon response to 
extracellular CDNs was not due to trace amounts of DNA or other non-specific 
contaminants in the synthetic CDN preparations, as the response was 
abolished by the addition of snake venom phosphodiesterase, which 
specifically degrades CDNs.  
 Kaufmann and colleagues [1] provide evidence that cGAS can bind 
CDNs directly, as determined using pull-down experiments with immobilised 
CDNs and in vitro binding assays. Notably, the binding affinity of cGAS for 
different CDNs correlated with the extent of interferon-β expression elicited. 
For instance, in human cells, cyclic di-AMP binds cGAS and stimulates 
interferon production more potently than cyclic di-GMP, suggesting that cGAS 
may be able to provide a further layer of specificity to CDN recognition. The 
authors find that CDN binding by cGAS induces cGAS dimerisation in vitro, 
and promotes an interaction between cGAS and STING and their co-
localisation in a signalling complex in CDN-treated cells (Fig. 1).  
 The role of cGAS in sensing endocytosed CDNs differs from its role in 
the recognition of cytosolic DNA. First, despite an involvement of additional 
co-sensors and co-factors in DNA sensing, cGAS has been shown to be 
essential for the response to cytosolic DNA in many different systems, while 
its role in the detection of extracellular CDNs seems to be to enhance, rather 
than cause, the activation of STING. Second, cGAS seems to promote CDN-
induced STING activation through association with STING in a signalling 
complex, rather than through the production of cGAMP, which then diffuses 
through the cytosol and binds STING during DNA sensing (Fig. 1). The 
detection of extracellular CDNs by cGAS probably does not involve cGAMP 
production as intermediate [1]. This is shown in reconstitution experiments 
where STING-deficient RAW264.7 cells are supplemented with wild type 
STING or with the R231A STING mutant, which can respond to cGAMP, but 
fails to bind bacterial CDNs such as cyclic di-GMP [3]. The authors observe 
that R231A STING cannot rescue the response to extracellular cyclic di-GMP, 
while the cGAMP-dependent response to transfected DNA is sustained. This 
suggests that the binding of phagocytosed CDNs by cGAS instead results in a 
different mode of STING activation via interaction in a signalling complex and 
the promotion of CDN binding by STING [1]. While the authors find that 
residues in the active site of cGAS are important for the detection of 
extracellular CDNs, it is conceivable that this is because those residues might 
also mediate CDN binding. Thus, the function of cGAS might be more similar 
to that of the CDN and DNA co-sensor DDX41, which also binds DNA and 
cyclic di-nucleotides and promotes interferon induction by forming a complex 
with STING [4]. The question remains whether a cGAS-STING interaction 
could also play a role in DNA sensing, possibly aiding STING activation by 
making the transfer of cGAMP from cGAS to STING more efficient. Identifying 
which amino acid residues in cGAS and STING are important in mediating the 
interaction of the two proteins will be key to assess the relative contributions 
of cGAS catalytic activity and STING binding in the activation of STING under 
different circumstances.  
 Since the discovery of cGAS as cytosolic DNA sensor only a few years 
ago, its mechanism of action has been investigated in great detail. Novel 
functions of cGAS in different subcellular locations, including in the nucleus, 
have recently been discovered [5,6], and, as further demonstrated by 
Kaufmann and colleagues [1], cGAS function is not always restricted to DNA 
sensing and cGAMP production. Indeed, the way in which STING is activated 
by cGAS or other regulators appears to have consequences for its mode of 
signalling. The authors observe that after detection of extracellular CDNs, 
STING does not translocate to the ERGIC, but instead moves to perinuclear 
foci that depend on dynein-mediated transport for their formation (Fig. 1). This 
has parallels with other recent findings suggesting that different modes of 
STING activation exist, which influence its subcellular location and 
downstream signalling [7]. While the detection of extracellular CDNs causes 
the activation of TBK1 and IRF3, similar to conventional STING activation 
during DNA sensing, it is possible that the differential localisation of STING in 
dynein-dependent foci could make it susceptible to additional modes of 
regulation, or could induce alternative downstream effects, in addition to the 
interferon response. As extracellular CDNs act as a sign for bacterial, rather 
than viral, infection, it remains to be examined whether this mode of STING 
signalling is beneficial to the host during bacterial infection in vivo. Indeed, two 
other recently discovered CDN receptors, the oxidoreductase RECON and the 
ER membrane protein ERAdP promote the activation of the transcription 
factor NF-κB rather than IRF3, which results in a more pronounced anti-
bacterial, rather than anti-viral response [8,9]. As STING activation can also 
promote NF-κB activation as well as autophagy, which has anti-bacterial 
effects, the downstream consequences of STING activation after the detection 
of extracellular CDNs remains to be examined in more detail. 
 A further outstanding question concerns how extracellular CDNs gain 
access to the cytosol after endocytosis, as CDNs are unable to pass through 
intact membranes, and would require either non-specific membrane leakage, 
pore formation or an active transport process. Similar questions arise from the 
observation that dendritic cells can use phagocytosis to take up extracellular 
DNA released from tumour cells, which also causes a cytosolic cGAS- and 
STING-dependent interferon response [10]. It is possible that cGAS guards 
the cytosolic face of the endolysosomal membrane for release of DNA or 
CDNs, in order to detect locally elevated concentrations of phagocytosed 
PAMPs. 
 Kaufmann and colleagues have now demonstrated the existence of a 
novel cGAS-dependent mode of STING activation [1]. Further studies will tell 
whether local extracellular CDN concentrations would be sufficient to elicit 
such a response during infection. It is conceivable that this could be relevant 
for the immune system's interaction with commensal bacteria, for instance at 
barrier locations such as the gut or the skin. Overall, this study provides a 
further example for the multi-faceted regulation of STING signalling, beyond 
the core cGAS-cGAMP-STING axis, and demonstrates how STING can 
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Fig. 1: The innate immune response to extracellular and intracellular 
cyclic di-nucleotides.  
 
Extracellular cyclic di-nucleotides (CDNs) are taken up by clathrin-mediated 
endocytosis (left). After export or leakage from late endosomes, CDNs can 
bind cyclic GMP-AMP synthase (cGAS), which then dimerises and forms a 
complex with the CDN receptor STimulator of INterferon Genes (STING). 
STING and cGAS co-localise at dunein-dependent perinuclear foci in a 
signalling complex also containing TANK-binding kinase (TBK1) which then 
activates Interferon Regulatory Factor 3 (IRF3), leading to the transcription of 
interferon-β (IFN-β). In contrast, when CDNs are delivered directly into the 
cytosol by membrane permeabilisation or transfection ("intracellular" CDNs, 
right), they can bind to STING in a cGAS-independent manner, causing 
STING translocation from the endoplasmic reticulum (ER) to the ER-Golgi-
Intermediary Compartment (ERGIC) where TBK1 activation takes place. This 
is similar to the response to cytosolic DNA, where cGAS produces the 
mammalian cyclic di-nucleotide cGAMP (cyclic GMP-AMP), which also binds 
and activates STING.  
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